Early Christmas Sale - Ends Soon!
-35% Off Everything
PFE

Pfizer Inc. (PFE)

Last Price$26.5(0.8%)
Market Cap$150.9B
LTM Revenue
$60.1B
YoY Growth
-12.3%
3Y CAGR
-4.6%
5Y CAGR
+2.5%
Stock quality & Intrinsic value
5/10
42.3% undervalued

Pfizer Inc. Revenue

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
$52.5B
$51.3B
$48.4B
$48.4B
$48.3B
$50.0B
$67.8B
$67.4B
$59.0B
$51.6B
$49.6B
$48.9B
$52.8B
$52.5B
$53.6B
$51.8B
$41.9B
$81.3B
$100.3B
$58.5B
PFE
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for PFE and see if it's the right time to invest.
Dive in

Pfizer Inc. (PFE) Revenue comparison analysis

Crunching data... Almost there!

PFE key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Pfizer Inc.'s Revenue?

As of today, Pfizer Inc.'s last 12-month Revenue is $60.1B, based on the financial report for Sep 29, 2024 (Q3 2024).

2) What is Pfizer Inc.'s Revenue growth rate?

Over the last year, Pfizer Inc.'s Revenue growth was (12.3%). The average annual Revenue growth rates for Pfizer Inc. have been 6.2% over the past three years, 2.5% over the past five years.

3) Is Pfizer Inc.'s Revenue growth rate Good?

Over the last year, Pfizer Inc.'s Revenue growth was (12.3%), which is lower than industry growth of 0.1%. It indicates that Pfizer Inc.'s Revenue growth is Bad.

4) How does Pfizer Inc.'s Revenue growth rate compare to its peers?

Over the last year, Pfizer Inc.'s Revenue growth was (12.3%), which is lower than peer median growth of 7.2%. The list of peers includes JNJ, SNY, MRK, ABBV, AZN, NVS, BMY, LLY, AMGN, GILD etc.